Compounds > n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime
Page last updated: 2024-09-03

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and ceftazidime

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with ceftazidime in 1 studies

Compound Research Comparison

Studies
(n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime)		Trials
(n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime)		Recent Studies (post-2010)
(n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime)		Studies
(ceftazidime)		Trials
(ceftazidime)		Recent Studies (post-2010) (ceftazidime)
88036354253

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balcewich, M; Mark, BL; Stubbs, KA; Vocadlo, DJ1

Other Studies

1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and ceftazidime

ArticleYear
Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.
    The Journal of biological chemistry, 2007, Jul-20, Volume: 282, Issue:29

    Topics: Acetylglucosaminidase; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Humans; Kinetics; Models, Biological; Muramic Acids; Peptides; Quinolones; Vibrio cholerae

2007